~~<i id='3585771DBC'><strike id='3585771DBC'><tt id='3585771DBC'><pre id='3585771DBC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

focus

author：Wikipedia 2025-09-28 01:38:16 - browse：636

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

focus

knowledge

leisure time

focus

knowledge

EssayauthorMaraBuchbinderandherhusband,Jesse(right).CourtesyMaraBuchbinderMyhusband’scancercamebackt

WSS

Drastic changes should bring profitability, startup health insurers say

Medtronic CEO on promising devices for diabetes, hypertension

Friends ask where James Watson's attitudes about race came from

How to use technology to prevent future drug shortages

Meta's Zuckerberg and Chan on track to put $50 billion into science

Drastic changes should bring profitability, startup health insurers say

Wikipedia

focus

focus

Alkermes shareholders re

NIH trials fail to test meaningful long Covid therapies, experts say

Alkermes shareholders re

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Psychedelics group wrestles with new pharma identity

Chimpanzees, like humans and whales, get menopause: Study

Anesthesiologist group: stop taking Ozempic before surgery

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Walensky prepares to leave CDC — and Congress — behind

First Opinion Podcast: How to protect health care in times of war

knowledge

Physician subsidies by hospitals soar in wake of No Surprises Act

The pink breast cancer awareness ribbon needs a redesign

Maker of FluMist seeks to allow at

Maker of FluMist seeks to allow at

Readout Newsletter: What happened with Sarepta's Duchenne data

Friends ask where James Watson's attitudes about race came from

leisure time

focus

knowledge

knowledge